Unternehmen Stemcell Holdings, Inc. Other OTC
Aktien
STMM
US85858N2027
STMM
Pharmazeutika
Kurzporträt
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 427 378 000 | 423 104 220 ( 99,00 %) | 0 | 99,00 % |
Unternehmenskontakt
Stemcell Holdings, Inc.
5-9-15-3F, Minamiaoyama Minato-ku
107-0062, Tokyo
+81 3 3400 0077
http://www.stemcell-holdings.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
STEMCELL Technologies Canada, Inc.
STEMCELL Technologies Canada, Inc. Miscellaneous Commercial ServicesCommercial Services STEMCELL Technologies Canada, Inc. is a Canadian biotechnology company that develops specialty cell culture media, cell isolation systems, and accessory products for life science research. STEMCELL Technologies Canada is based in Vancouver, CA, and has subsidiaries in the United States, Canada, United Kingdom, and France. The private company offers a collection of scientific resources for chimerism research, including videos, technical bulletins, and scientific posters. The company also provides automation of key laboratory processes with their portfolio of instruments that can significantly improve the efficiency of research programs. The company was founded in 1993 by Allen Charles Eaves, who has been the CEO since 1993. |
Miscellaneous Commercial Services
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-2,00 % | 90,27 Mrd. | |
-1,18 % | 40,12 Mrd. | |
-15,83 % | 31,75 Mrd. | |
+62,86 % | 26,6 Mrd. | |
-21,68 % | 14,41 Mrd. | |
-8,73 % | 12,92 Mrd. | |
-15,05 % | 11,44 Mrd. | |
-45,69 % | 11,3 Mrd. | |
+4,94 % | 8,87 Mrd. |